$TBPH
Theravance Biopharma, Inc.
XNAS•Health Care•Pharmaceutical Preparations
$17.03
▼-0.06%-$0.010
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateTheravance Biopharma, Inc.
XNAS•Health Care•Pharmaceutical Preparations
Why is TBPH up today? It is at $17.03 (+0.00%), and our scanner flagged it 1 time on unusual volume this month. See the catalyst behind the move, real-time alerts the moment TBPH spikes, and full due diligence on TBPH — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $TBPH 1 time in the last 30 days. Create a free account to track $TBPH, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on TBPH from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for TBPH today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystMerger / acquisition agreementPrice $0.05/share, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Sep 17, 2026 · todaySources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Farnum Rhonda Officer | Sold (automatic/other) | -6K 0.01% of company | sold 2.4% | 227K | $96K at $16.95 | Aug 20, 26 |
Grimaud Brett A. Officer | Sold (automatic/other) | -8K 0.02% of company | sold 2.2% | 355K | $135K at $16.95 | Aug 20, 26 |
Miller Aine Officer | Sold (automatic/other) | -6K 0.01% of company | sold 3.2% | 190K | $106K at $16.95 | Aug 20, 26 |
Sawaf Aziz Officer | Sold (automatic/other) | -8K 0.02% of company | sold 2.4% | 337K | $137K at $16.95 | Aug 20, 26 |
Winningham Rick E Officer | Sold (automatic/other) | -20K 0.04% of company | sold 1.2% | 1.61M | $340K at $16.95 | Aug 20, 26 |
Samaha Eli Beneficial Owner (10%) | Sold (automatic/other) | -6K 0.01% of company | sold <0.1% | 9.17M | $96K at $17.17 | Jul 7, 26 |
Samaha Eli Beneficial Owner (10%) | Sold (automatic/other) | -1K | sold <0.1% | 9.17M | $24K at $17.04 | Jul 6, 26 |
Samaha Eli Beneficial Owner (10%) | Sold (automatic/other) | -38K 0.07% of company | sold 0.4% | 9.17M | $643K at $17.00 | Jul 1, 26 |
Samaha Eli Beneficial Owner (10%) | Sold (automatic/other) | -25K 0.05% of company | sold 0.3% | 9.21M | $429K at $17.13 | Jun 30, 26 |
Samaha Eli Beneficial Owner (10%) | Sold (automatic/other) | -274K 0.5% of company | sold 2.9% | 9.24M | $4.7M at $17.23 | Jun 29, 26 |
Miller Aine Officer | Acquired (grant/award) | +19K 0.04% of company | added 11% | 196K | n/a | Jun 19, 26 |
Farnum Rhonda Officer | Sold (automatic/other) | -13K 0.03% of company | sold 5.4% | 232K | $218K at $16.38 | Jun 15, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on TBPH from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for TBPH today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
TBPH last traded at $17.03, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Theravance Biopharma, Inc. (TBPH) is next expected to report earnings on Monday, November 9, 2026, about 53 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The TBPH Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged TBPH 1 time in the last 30 days.
TBPH (Theravance Biopharma, Inc.) trades on XNAS, with a market cap of about $884M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge TBPH for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$TBPH discussion
Sign in to ask a question or join the discussion.